Intermedical Care and Lab Hospital PCL (BKK:IMH)
Thailand · Delayed Price · Currency is THB 3.000
0.00 (0.00%)
Feb 11, 2026, 10:01 AM ICT
BKK:IMH Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 766.61 | 771.07 | 669.61 | 639.83 | 942.64 | 238.21 |
Other Revenue | 14.34 | 7.16 | 7.04 | 11.37 | 10.25 | 4.34 |
| 780.94 | 778.22 | 676.65 | 651.2 | 952.88 | 242.55 | |
Revenue Growth (YoY) | -2.35% | 15.01% | 3.91% | -31.66% | 292.87% | -27.84% |
Cost of Revenue | 672.67 | 618.13 | 430.68 | 304.85 | 315.55 | 180.22 |
Gross Profit | 108.27 | 160.1 | 245.97 | 346.36 | 637.34 | 62.32 |
Selling, General & Admin | 218.3 | 143.62 | 143.73 | 124.31 | 105.78 | 78.38 |
Other Operating Expenses | 24.63 | 37.66 | 35.02 | - | - | - |
Operating Expenses | 242.94 | 181.28 | 178.75 | 124.31 | 105.78 | 78.38 |
Operating Income | -134.66 | -21.19 | 67.23 | 222.05 | 531.56 | -16.06 |
Interest Expense | -44.59 | -54.68 | -36.49 | -10.82 | -8.75 | -1.54 |
EBT Excluding Unusual Items | -179.25 | -75.87 | 30.74 | 211.23 | 522.8 | -17.6 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.2 |
Pretax Income | -179.25 | -75.87 | 30.74 | 211.23 | 522.8 | -17.39 |
Income Tax Expense | -7.62 | 2.01 | 11.98 | 38.12 | 100.1 | -0.79 |
Earnings From Continuing Operations | -171.64 | -77.88 | 18.76 | 173.1 | 422.7 | -16.61 |
Minority Interest in Earnings | 2.98 | 3.43 | 0.33 | 0.01 | - | - |
Net Income | -168.66 | -74.46 | 19.09 | 173.11 | 422.7 | -16.61 |
Net Income to Common | -168.66 | -74.46 | 19.09 | 173.11 | 422.7 | -16.61 |
Net Income Growth | - | - | -88.97% | -59.05% | - | - |
Shares Outstanding (Basic) | 222 | 214 | 214 | 214 | 215 | 215 |
Shares Outstanding (Diluted) | 222 | 214 | 214 | 214 | 215 | 215 |
Shares Change (YoY) | 3.51% | - | 0.00% | -0.34% | -0.12% | 33.25% |
EPS (Basic) | -0.76 | -0.35 | 0.09 | 0.81 | 1.97 | -0.08 |
EPS (Diluted) | -0.76 | -0.35 | 0.09 | 0.81 | 1.97 | -0.08 |
EPS Growth | - | - | -88.97% | -58.91% | - | - |
Free Cash Flow | 89.97 | 90.45 | 65.49 | 38.64 | 337.67 | -31.03 |
Free Cash Flow Per Share | 0.41 | 0.42 | 0.31 | 0.18 | 1.57 | -0.14 |
Dividend Per Share | - | - | - | 0.140 | 0.900 | - |
Dividend Growth | - | - | - | -84.44% | - | - |
Gross Margin | 13.86% | 20.57% | 36.35% | 53.19% | 66.88% | 25.70% |
Operating Margin | -17.24% | -2.72% | 9.93% | 34.10% | 55.78% | -6.62% |
Profit Margin | -21.60% | -9.57% | 2.82% | 26.58% | 44.36% | -6.85% |
Free Cash Flow Margin | 11.52% | 11.62% | 9.68% | 5.93% | 35.44% | -12.79% |
EBITDA | -97.08 | 17.6 | 100.27 | 245.8 | 552.88 | 2.17 |
EBITDA Margin | -12.43% | 2.26% | 14.82% | 37.75% | 58.02% | 0.90% |
D&A For EBITDA | 37.58 | 38.79 | 33.05 | 23.75 | 21.32 | 18.23 |
EBIT | -134.66 | -21.19 | 67.23 | 222.05 | 531.56 | -16.06 |
EBIT Margin | -17.24% | -2.72% | 9.93% | 34.10% | 55.78% | -6.62% |
Effective Tax Rate | - | - | 38.97% | 18.05% | 19.15% | - |
Revenue as Reported | 780.94 | 778.22 | 676.65 | 651.2 | 952.88 | 242.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.